Andrew Hedin

Andrew Hedin is a Board of Director at Kymera Therapeutics. He's also the Vice President in Bessemer’s Cambridge office, where he focuses on investments in healthcare. Prior to joining Bessemer in 2015, Andrew worked at F-Prime Capital, Fidelity’s healthcare-focused venture capital fund. While there, he invested broadly across healthcare in early stage healthcare tech, healthcare services, biotech and medtech startups. Andrew has also worked with Health Essentials, a healthcare services company focused on providing post-acute and coordinated care to the frail elderly. Andrew began his career at Leerink Partners, a boutique healthcare-focused firm where he focused on growth strategies for pharmaceutical, biotech and medical device companies. Andrew holds an MBA with honors from The Wharton School, where he majored in Health Care Management and Finance, as well as a B.A. in Biological Basis of Behavior from the University of Pennsylvania, where he conducted research in both the neuroscience and psychology departments. Andrew also serves on the steering committee of the New England Venture Network, the largest group of young venture capitalists in the New England area.